1. Medici BB, Nygaard B, la Cour JL, Grand MK, Siersma V, Nicolaisdottir DR, et al. Changes in Prescription Routines for Treating Hypothyroidism Between 2001 and 2015: An Observational Study of 929,684 Primary Care Patients in Copenhagen. Thyroid. 2019 Jul;29(7):910-19. https://doi.org/10.1089/thy.2018.0539. [ DOI] [ PubMed] 2. Casula S, Ettleson MD, Bianco AC. Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism? Endocr Pract. 2023 Jul;29(7):581-88. https://doi.org/10.1016/j.eprac.2023.04.003. [ DOI] [ PubMed] 3. Ross DS. Treating hypothyroidism is not always easy: When to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy. J Intern Med. 2022 Feb;291(2):128-40. https://doi.org/10.1111/joim.13410. [ DOI] [ PubMed] 4. Ettleson MD, Papaleontiou M. Evaluating health outcomes in the treatment of hypothyroidism. Front Endocrinol (Lausanne). 2022 Oct;13:1026262. https://doi.org/10.3389/fendo.2022.1026262. [ DOI] [ PubMed] 5. Salvatore D, Porcelli T, Ettleson MD, Bianco AC. The relevance of T3 in the management of hypothyroidism. Lancet Diabetes Endocrinol. 2022 May;10(5):366-72. https://doi.org/10.1016/s2213-8587(22)00004-3. [ DOI] [ PubMed] 6. Premawardhana LD, Taylor PN, Okosieme OE, Adlan MA, Obuobie EK, Dayan CM. Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design. Front Endocrinol (Lausanne). 2023 Nov;14:1282608. https://doi.org/10.3389/fendo.2023.1282608. [ DOI] [ PubMed] 7. Jonklaas J, Bianco AC, Cappola AR, Celi FS, Fliers E, Heuer H, et al. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document. Thyroid. 2021 Feb;31(2):156-82. https://doi.org/10.1089/thy.2020.0720. [ DOI] [ PubMed] 8. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997 Sep;12(9):544-50. https://doi.org/10.1046/j.1525-1497.1997.07109.x. [ DOI] [ PubMed] 9. Jansen HI, Boelen A, Heijboer AC, Bruinstroop E, Fliers E. Hypothyroidism: The difficulty in attributing symptoms to their underlying cause. Front Endocrinol (Lausanne). 2023 Feb;14:1130661. https://doi.org/10.3389/fendo.2023.1130661. [ DOI] [ PubMed] 10. Perros P, Hegedüs L, Nagy EV, Papini E, Hay HA, Abad-Madroñero J, et al. The Impact of Hypothyroidism on Satisfaction with Care and Treatment and Everyday Living: Results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient Survey. Thyroid. 2022 Oct;32(10):1158-68. https://doi.org/10.1089/thy.2022.0324. [ DOI] [ PubMed] 11. Perros P, Van Der Feltz-Cornelis C, Papini E, Nagy EV, Weetman AP, Hegedüs L. The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: A narrative review. Clin Endocrinol (Oxf). 2023 Apr;98(4):461-68. https://doi.org/10.1111/cen.14473. [ DOI] [ PubMed] 12. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014 Dec;24(12):1670-751. https://doi.org/10.1089/thy.2014.0028. [ DOI] [ PubMed] 13. Ettleson MD, Bianco AC. Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone? J Clin Endocrinol Metab. 2020 Sep;105(9):e3090–104. https://doi.org/10.1210/clinem/dgaa430. [ DOI] [ PubMed] 14. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017 Sep;390(10101):1550-62. https://doi.org/10.1016/s0140-6736(17)30703-1. [ DOI] [ PubMed] 15. Peterson SJ, Cappola AR, Castro MR, Dayan CM, Farwell AP, Hennessey JV, et al. An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction. Thyroid. 2018 Jun;28(6):707-21. https://doi.org/10.1089/thy.2017.0681. [ DOI] [ PubMed] 16. Ashraf H, Heydari M, Shams M, Zarshenas MM, Tavakoli A, Sayadi M. Efficacy of Ginger Supplementation in Relieving Persistent Hypothyroid Symptoms in Patients with Controlled Primary Hypothyroidism: A Pilot Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Evid Based Complement Alternat Med. 2022 Jan;2022:5456855. https://doi.org/10.1155/2022/5456855. [ DOI] [ PubMed] 17. McAninch EA, Rajan KB, Miller CH, Bianco AC. Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2018 Aug;103(12):4533-42. https://doi.org/10.1210/jc.2018-01361. [ DOI] [ PubMed] 18. Wang X, Wu Z, Liu Y, Wu C, Jiang J, Hashimoto K, et al. The role of thyroid-stimulating hormone in regulating lipid metabolism: Implications for body-brain communication. Neurobiol Dis. 2024 Oct;201:106658. https://doi.org/10.1016/j.nbd.2024.106658. [ DOI] [ PubMed] 19. Groenewegen KL, Mooij CF, van Trotsenburg ASP. Persisting symptoms in patients with Hashimoto's disease despite normal thyroid hormone levels: Does thyroid autoimmunity play a role? A systematic review. J Transl Autoimmun. 2021 Apr;4:100101. https://doi.org/10.1016/j.jtauto.2021.100101. [ DOI] [ PubMed] 20. Tousief Irshad A, Irshad S. Higher anti-TPO antibody titers are associated with greater thyroid-related symptomatology. Eur J Mol Clin Med. 2022;9(1):663-71. [ Link] 21. Jayashankar CA, Avinash S, Shashidharan B, Vijaya S, Shruthi KR, Nikethan D, et al. The prevalence of anti-thyroid peroxidase antibodies in subclinica and clinical hypothyroid patients. Int J Res Med Sci. 2015;3(12):3564-66. https://doi.org/10.18203/2320-6012.ijrms20151399. [ Link] [ DOI] 22. Biondi B, Celi FS, McAninch EA. Critical Approach to Hypothyroid Patients With Persistent Symptoms. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2708-2716. https://doi.org/10.1210/clinem/dgad224. [ DOI] [ PubMed] 23. Freeman MK, Adunlin GA, Mercadel C, Danzi S, Klein I. Hypothyroid Symptoms in Levothyroxine-Treated Patients. Innov Pharm. 2019 Oct;10(3):10.24926/iip.v10i3.2026. https://doi.org/10.24926/iip.v10i3.2026. [ DOI] [ PubMed] 24. Molewijk E, Martens M, Fliers E, Zelissen P, Dreijerink K, van Dooren A, et al. Reduced quality of life and persistent complaints in treated hypothyroid patients. 20th European Congress of Endocrinology. 19 May 2018 - 22 May 2018. Barcelona, Spain. [ Link] 25. Bessell E, Markovic TP, Fuller NR. How to provide a structured clinical assessment of a patient with overweight or obesity. Diabetes Obes Metab. 2021 Feb;23(1):36-49. https://doi.org/10.1111/dom.14230. [ DOI] [ PubMed] 26. Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Skin changes in the obese patient. J Am Acad Dermatol. 2019 Nov;81(5):1037-57. https://doi.org/10.1016/j.jaad.2018.12.070. [ DOI] [ PubMed] 27. Dąbrowska AK, Spano F, Derler S, Adlhart C, Spencer ND, Rossi RM. The relationship between skin function, barrier properties, and body-dependent factors. Skin Res Technol. 2018 May;24(2):165-74. https://doi.org/10.1111/srt.12424. [ DOI] [ PubMed] 28. Fitzgerald SP, Bean NG, Falhammar H, Tuke J. Clinical Parameters Are More Likely to Be Associated with Thyroid Hormone Levels than with Thyrotropin Levels: A Systematic Review and Meta-Analysis. Thyroid. 2020 Dec;30(12):1695-709. https://doi.org/10.1089/thy.2019.0535. [ DOI] [ PubMed] 29. Imaizumi M, Sera N, Ueki I, Horie I, Ando T, Usa T, et al. Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism. Thyroid. 2011 Nov;21(11):1177-82. https://doi.org/10.1089/thy.2010.0411. [ DOI] [ PubMed] |
